Clinical trial NCT05057143: 3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors
Official title: The Use of Individual 3D-implants in the Reconstruction of the Chest Wall in Patients With the Tumor Lesions of the Chest Wall for the Treatment, Restoration, and Improved Quality of Life Compared to Reconstruction With Titanium Plates
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Tumor of Bone
Chest Wall Tumor
Chest Wall Sarcoma
Sarcoma of Bone
Surgery
Implant Site Reaction
Keywords: Chest Wall Tumor
Surgery
Lead sponsor: Blokhin's Russian Cancer Research Center
Sponsor class: OTHER
First posted: 2021-09-27
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: A patient with a tumor lesion of the chest wall undergoes CT scan with a step width of less than 1 mm, then engineers design an individual model to replace the defect. Using a 3D printer, a model is made based on titanium alloy powder. Preoperative preparation takes an average of 14-21 days. The next stage is surgical treatment in the amount of resection of the chest wall with plastic defect with an individual titanium implant. In some cases, the titanium framework is separated from the pleural cavity by a polytetrafluoroethylene plate in order to seal and prevent the development of pulmonary hernias. The advantages of titanium individual prostheses include accurate matching of the implant to the size and characteristics of the defect, individual modeling allows you to repeat the anatomical features of the patient. This method helps to recreate the original shape of the chest, and most importantly, symmetrical, relatively healthy half. With the help of titanium, individualized prostheses are made based on 3D modeling, which will reduce the incidence of complications, accelerate rehabilitation and improve the quality of life of patients with tumor lesions of the chest wall. The postoperative period takes 15-30 days.

Detailed description: A patient with a tumor lesion of the chest wall undergoes CT scan with a step width of less than 1 mm, then engineers design an individual model to replace the defect. Using a 3D printer, a model is made based on the patient's anthropometric data.

Manufacturing takes place by 3D printing on a titanium alloy powder certified for the manufacture of medical implants. The technology used is a type of SLS (Selective Laser Sintering) -technology, layer-by-layer laser melting of metal-powder compositions. The printing process begins with dividing the digital 3D model of the product into layers with a thickness of 20 to 100 microns in order to create a 2D image of each layer of the product (section). The industry standard format is STL (Stereolithography) file. This file enters a special machine software, where the information is analyzed and compared with the technical capabilities of the machine. Based on the data obtained, a production cycle of construction is launched, consisting of many cycles of building individual layers of the product.

The cycle for constructing a layer (section) consists of typical operations:

* applying a layer of powder of a given thickness to the construction plate;
* scanning by a laser beam of the section of the product layer. The laser beam is a source of heat, under the influence of which the particles of the material are sintered along the profile of the section of the model;
* lowering the platform into the depth of the construction well by an amount corresponding to the thickness of the construction layer.

The process of building products takes place in the SLM (Selective Laser Melting) chamber of the machine, filled with an inert gas argon. After construction, the product is removed from the printer chamber and sent for heat treatment, annealing, to relieve internal stresses and improve mechanical properties. After annealing, the product is separated from the platform and undergoes finishing, which combines various types of machining. The final stages of the technological process are product cleaning and technical quality control.

Preoperative preparation takes an average of 14-21 days. The next stage is surgical treatment in the amount of resection of the chest wall with plastic defect with an individual titanium implant. In all cases, the titanium framework is separated from the pleural cavity by a synthetic polyester (Dacron) plate in order to seal and prevent the development of pulmonary hernias. The advantages of titanium individual implants include accurate matching of the implant to the size and characteristics of the defect, individual modeling allows you to repeat the anatomical features of the patient. This method helps to recreate the original shape of the chest, and most importantly, symmetrical, relatively healthy half. With the help of titanium, individualized prostheses are made based on 3D modeling, which will reduce the incidence of complications, accelerate rehabilitation and improve the quality of life of patients with tumor lesions of the chest wall. The postoperative period takes 15-30 days.

Eligibility criteria: Inclusion Criteria:

* Malignant neoplasm of ribs, sternum and clavicle
* Malignant neoplasm of the connective and soft tissues of the chest
* Neoplasm of uncertain or unknown nature of ribs, sternum and collarbone
* Benign neoplasm of ribs, sternum and collarbone
* Tumor lesions of the chest wall of any localization, malignant and benign, as well as of an uncertain or unknown nature
* For malignant tumors: Grade 1-3
* Lack of distant metastases
* Signed informed consent

Exclusion Criteria:

* Children, women during pregnancy, childbirth, women during breastfeeding.
* Military personnel, with the exception of contract military personnel.
* Persons with mental disorders.
* Persons detained, taken into custody, serving a sentence in the form of restriction of freedom, arrest, imprisonment or administrative arrest.
* Patients with distant metastases (except for a solitary focus in the chest wall without other manifestations of the disease)
* Inoperable tumor
* The presence of another malignant tumor at the time of examination
* ECOG 4
* Having an active or chronic fungal / bacterial / viral infection
* Uncontrolled chronic diseases of the liver, kidneys in the acute stage
* Presence of metastases

Primary outcomes:
measure: Disease-free survival
timeFrame: 24 months
Secondary outcomes:
measure: Comparison of hospitalization rate
timeFrame: 30 days
measure: Comparison of safety assessment
timeFrame: 24 months
measure: Comparison of performance status according Karnofsky scale
timeFrame: 24 months
measure: Comparison of pain relief according Visual Analogue Scale
timeFrame: 24 months
measure: Comparison of pain relief according Whatkins scale
timeFrame: 24 months
Other outcomes:
Locations:
city: Moscow
country: Russian Federation
facility: Federal State Budgetary Institution "N.N. Blokhin National Medical Research Center of Oncology" оf the Ministry of Health of the Russian Federation
Study officials:
affiliation: N.N. Blokhin NMRCO
name: Aslan Valiev, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: N.N. Blokhin NMRCO
name: Pavel Kononets, PhD
role: PRINCIPAL_INVESTIGATOR
References: